Regeneron Pharmaceuticals Inc (REGN) Financials
Key financial figures for Regeneron Pharmaceuticals Inc (Q2 2026).
- Revenue
- $4.3B
- Net Income
- $1.3B
- EPS
- $12.62
- Total Assets
- $41.7B
- Operating Cash Flow
- $813M
Full income statement, balance sheet, and cash flow for Regeneron Pharmaceuticals Inc on SentiSense.